Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
. (2018) Theme 7 Pre-clinical therapeutic strategies. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 217-239.
Read now
Read now
. (2018) ALSUntangled 43: copper. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 472-476.
Read now
Read now
Ana Martinez, Maria del Valle Palomo Ruiz, Daniel I. Perez & Carmen Gil. (2017) Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 26:4, pages 403-414.
Read now
Read now
. (2014) THEME 11 THERAPEUTIC STRATEGIES. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:sup1, pages 197-211.
Read now
Read now
Articles from other publishers (62)
Richa, Vinod Kumar & Ramesh Kataria. (2024) Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity. Journal of Inorganic Biochemistry 251, pages 112440.
Crossref
Crossref
Yue Yang, Dominic Rowe, Heather McCann, Claire E. Shepherd, Jillian J. Kril, Matthew C. Kiernan, Glenda M. Halliday & Rachel H. Tan. (2023) Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS. Neuropathology and Applied Neurobiology 49:4.
Crossref
Crossref
Bichao Zhang & Richard Burke. (2023) Copper homeostasis and the ubiquitin proteasome system. Metallomics 15:3.
Crossref
Crossref
Sara Nikseresht, James B.W. Hilton, Jeffrey R. Liddell, Kai Kysenius, Ashley I. Bush, Scott Ayton, HuiJing Koay, Paul S. Donnelly & Peter J. Crouch. (2023) Transdermal Application of Soluble CuII(atsm) Increases Brain and Spinal Cord Uptake Compared to Gavage with an Insoluble Suspension. Neuroscience 509, pages 125-131.
Crossref
Crossref
Muhammad Ismail, Wen Yang, Yanfei Li, Yibin Wang, Wenya He, Jiefei Wang, Pir Muhammad, Timothy B. Chaston, Fawad Ur Rehman, Meng Zheng, David B. Lovejoy & Bingyang Shi. (2022) Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials 289, pages 121760.
Crossref
Crossref
Xin Yi Choo, Lachlan E. McInnes, Alexandra Grubman, Joanna M. Wasielewska, Irina Belaya, Emma Burrows, Hazel Quek, Jorge Cañas Martín, Sanna Loppi, Annika Sorvari, Dzhessi Rait, Andrew Powell, Clare Duncan, Jeffrey R. Liddell, Heikki Tanila, Jose M. Polo, Tarja Malm, Katja M. Kanninen, Paul S. Donnelly & Anthony R. White. (2022) Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex. International Journal of Molecular Sciences 23:18, pages 10722.
Crossref
Crossref
Mikayla L. Brown, Luke McAlary, Jeremy S. Lum, Natalie E. Farrawell & Justin J. Yerbury. (2022) Cells Overexpressing ALS-Associated SOD1 Variants Are Differentially Susceptible to CuATSM-Associated Toxicity. ACS Chemical Neuroscience 13:16, pages 2371-2379.
Crossref
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Crossref
Jeremy S. Lum, Mikayla L. Brown, Natalie E. Farrawell, Luke McAlary, Diane Ly, Christen G. Chisholm, Josh Snow, Kara L. Vine, Tim Karl, Fabian Kreilaus, Lachlan E. McInnes, Sara Nikseresht, Paul S. Donnelly, Peter J. Crouch & Justin J. Yerbury. (2021) CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background. Scientific Reports 11:1.
Crossref
Crossref
May T. Maung, Alyssa Carlson, Monserrat Olea‐Flores, Lobna Elkhadragy, Kyle M. Schachtschneider, Napoleon Navarro‐Tito & Teresita Padilla‐Benavides. (2021) The molecular and cellular basis of copper dysregulation and its relationship with human pathologies. The FASEB Journal 35:9.
Crossref
Crossref
Michail S. Kukharsky, Veronika I. Skvortsova, Sergey O. Bachurin & Vladimir L. Buchman. (2020) In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches. Medicinal Research Reviews 41:5, pages 2804-2822.
Crossref
Crossref
Xiaowen Shi, Yasuyuki Ohta, Yumiko Nakano, Xia Liu, Koh Tadokoro, Tian Feng, Emi Nomura, Keiichiro Tsunoda, Ryo Sasaki, Namiko Matsumoto, Yosuke Osakada, Yuting Bian, Zhihong Bian, Yoshio Omote, Mami Takemoto, Nozomi Hishikawa, Toru Yamashita & Koji Abe. (2021) Neuroprotective effect of CuATSM in mice stroke model by ameliorating oxidative stress. Neuroscience Research 166, pages 55-61.
Crossref
Crossref
Jessica R. Morrice, Michael Kuo & Christopher A. Shaw. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
181
199
.
Benjamin G. Trist, James B. Hilton, Dominic J. Hare, Peter J. Crouch & Kay L. Double. (2020) Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. Angewandte Chemie International Edition 60:17, pages 9215-9246.
Crossref
Crossref
Benjamin G. Trist, James B. Hilton, Dominic J. Hare, Peter J. Crouch & Kay L. Double. (2020) Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. Angewandte Chemie 133:17, pages 9299-9330.
Crossref
Crossref
Chika Takashima, Yasuhiro Kosuge, Masahisa Inoue, Shin-Ichi Ono & Eiichi Tokuda. (2021) A Metal-Free, Disulfide Oxidized Form of Superoxide Dismutase 1 as a Primary Misfolded Species with Prion-Like Properties in the Extracellular Environments Surrounding Motor Neuron-Like Cells. International Journal of Molecular Sciences 22:8, pages 4155.
Crossref
Crossref
Pavlína Hemerková & Martin Vališ. (2021) Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies. Biomolecules 11:3, pages 437.
Crossref
Crossref
Cyril Jones Jagaraj, Sonam Parakh & Julie D. Atkin. (2021) Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Peng Lei, Scott Ayton & Ashley I. Bush. (2021) The essential elements of Alzheimer’s disease. Journal of Biological Chemistry 296, pages 100105.
Crossref
Crossref
Grażyna Gromadzka, Beata Tarnacka, Anna Flaga & Agata Adamczyk. (2020) Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications. International Journal of Molecular Sciences 21:23, pages 9259.
Crossref
Crossref
Sara Nikseresht, James B.W. Hilton, Kai Kysenius, Jeffrey R. Liddell & Peter J. Crouch. (2020) Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond. Life 10:11, pages 271.
Crossref
Crossref
Luke McAlary, Yee Lian Chew, Jeremy Stephen Lum, Nicholas John Geraghty, Justin John Yerbury & Neil R. Cashman. (2020) Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Masamichi Ikawa, Hidehiko Okazawa, Yasunari Nakamoto & Makoto Yoneda. (2020) PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction. Antioxidants 9:9, pages 861.
Crossref
Crossref
Federica Violi, Nikolay Solovyev, Marco Vinceti, Jessica Mandrioli, Marianna Lucio & Bernhard Michalke. (2020) The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis. Metallomics 12:5, pages 668-681.
Crossref
Crossref
Afshin Montazeri, Milad Akhlaghi, Ahmad Reza Barahimi, Ali Jahanbazi Jahan Abad & Reza Jabbari. (2020) The Role of Metals in Neurodegenerative Diseases of the Central Nervous System. The Neuroscience Journal of Shefaye Khatam 8:2, pages 130-146.
Crossref
Crossref
Adam Southon, Kathryn Szostak, Karla M. Acevedo, Krista A. Dent, Irene Volitakis, Abdel A. Belaidi, Kevin J. Barnham, Peter J. Crouch, Scott Ayton, Paul S. Donnelly & Ashley I. Bush. (2020)
Cu
II
(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
. British Journal of Pharmacology 177:3, pages 656-667.
Crossref
Crossref
Michael T.H. Kuo, Joseph S. Beckman & Christopher A. Shaw. (2019) Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model. Neurobiology of Disease 130, pages 104495.
Crossref
Crossref
Manish K. Tiwari, Per M. Hägglund, Ian Max Møller, Michael J. Davies & Morten J. Bjerrum. (2019) Copper ion / H2O2 oxidation of Cu/Zn-Superoxide dismutase: Implications for enzymatic activity and antioxidant action. Redox Biology 26, pages 101262.
Crossref
Crossref
Brett M. Paterson, Carleen Cullinane, Peter J. Crouch, Anthony R. White, Kevin J. Barnham, Peter D. Roselt, Wayne Noonan, David Binns, Rodney J. Hicks & Paul S. Donnelly. (2019) Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups. Inorganic Chemistry 58:7, pages 4540-4552.
Crossref
Crossref
Natalie E. Farrawell, Maddison R. Yerbury, Steven S. Plotkin, Luke McAlary & Justin J. Yerbury. (2018)
CuATSM Protects Against the
In Vitro
Cytotoxicity of Wild-Type-Like Copper–Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding
. ACS Chemical Neuroscience 10:3, pages 1555-1564.
Crossref
Crossref
Gareth S. A. Wright, Svetlana V. Antonyuk & S. Samar Hasnain. (2019) The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis. Quarterly Reviews of Biophysics 52.
Crossref
Crossref
Ryan J. Keenan, Jacky Chan, Paul S. Donnelly, Kevin J. Barnham & Laura H. Jacobson. (2018) The social defeat/overcrowding murine psychosocial stress model results in a pharmacologically reversible body weight gain but not depression - related behaviours. Neurobiology of Stress 9, pages 176-187.
Crossref
Crossref
Timothy A. Su, Diyala S. Shihadih, Wendy Cao, Tyler C. Detomasi, Marie C. Heffern, Shang Jia, Andreas Stahl & Christopher J. Chang. (2018) A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals. Journal of the American Chemical Society 140:42, pages 13764-13774.
Crossref
Crossref
Xin Yi Choo, Jeffrey R. Liddell, Mikko T. Huuskonen, Alexandra Grubman, Diane Moujalled, Jessica Roberts, Kai Kysenius, Lauren Patten, Hazel Quek, Lotta E. Oikari, Clare Duncan, Simon A. James, Lachlan E. McInnes, David J. Hayne, Paul S. Donnelly, Eveliina Pollari, Suvi Vähätalo, Katarína Lejavová, Mikko I. Kettunen, Tarja Malm, Jari Koistinaho, Anthony R. White & Katja M. Kanninen. (2018) CuII(atsm) Attenuates Neuroinflammation. Frontiers in Neuroscience 12.
Crossref
Crossref
James B. Hilton, Kai Kysenius, Anthony R. White & Peter J. Crouch. (2018) The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1G37R mouse model of ALS and can be restored by overexpressing the human copper transporter hCTR1. Experimental Neurology 307, pages 118-128.
Crossref
Crossref
Rossana Sirabella, Valeria Valsecchi, Serenella Anzilotti, Ornella Cuomo, Antonio Vinciguerra, Pasquale Cepparulo, Paola Brancaccio, Natascia Guida, Nicolas Blondeau, Lorella M. T. Canzoniero, Cristina Franco, Salvatore Amoroso, Lucio Annunziato & Giuseppe Pignataro. (2018) Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets. Frontiers in Neuroscience 12.
Crossref
Crossref
T. Gabriel Enge, Heath Ecroyd, Dianne F. Jolley, Justin J. Yerbury, Bernadett Kalmar & Anthony Dosseto. (2018) Assessment of metal concentrations in the SOD1G93A mouse model of amyotrophic lateral sclerosis and its potential role in muscular denervation, with particular focus on muscle tissue. Molecular and Cellular Neuroscience 88, pages 319-329.
Crossref
Crossref
Sahar Sheykhansari, Kristen Kozielski, Joachim Bill, Metin Sitti, Donato Gemmati, Paolo Zamboni & Ajay Vikram Singh. (2018) Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death & Disease 9:3.
Crossref
Crossref
Alexandre Henriques, Vincent Croixmarie, Alexandra Bouscary, Althéa Mosbach, Céline Keime, Claire Boursier-Neyret, Bernard Walter, Michael Spedding & Jean-Philippe Loeffler. (2018) Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Jeffrey Liddell. (2017) Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?. Antioxidants 6:3, pages 65.
Crossref
Crossref
Fernando G. Vieira, Theo Hatzipetros, Kenneth Thompson, Andy J. Moreno, Joshua D. Kidd, Valerie R. Tassinari, Beth Levine, Steven Perrin & Alan Gill. (2017) CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Reports 2, pages 47-53.
Crossref
Crossref
Mikko T. Huuskonen, Qing-zhang Tuo, Sanna Loppi, Hiramani Dhungana, Paula Korhonen, Lachlan E. McInnes, Paul S. Donnelly, Alexandra Grubman, Sara Wojciechowski, Katarina Lejavova, Yuriy Pomeshchik, Laura Periviita, Lotta Kosonen, Martina Giordano, Frederick R. Walker, Rong Liu, Ashley I. Bush, Jari Koistinaho, Tarja Malm, Anthony R. White, Peng Lei & Katja M. Kanninen. (2017) The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu. Neurotherapeutics 14:2, pages 519-532.
Crossref
Crossref
Stefanie M. A. Willekens, Donatienne Van Weehaeghe, Philip Van Damme & Koen Van Laere. (2016) Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks. European Journal of Nuclear Medicine and Molecular Imaging 44:3, pages 533-547.
Crossref
Crossref
James B. Hilton, Stephen W. Mercer, Nastasia K. H. Lim, Noel G. Faux, Gojko Buncic, Joseph S. Beckman, Blaine R. Roberts, Paul S. Donnelly, Anthony R. White & Peter J. Crouch. (2017) CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord. Scientific Reports 7:1.
Crossref
Crossref
T. Gabriel Enge, Heath Ecroyd, Dianne F. Jolley, Justin J. Yerbury & Anthony Dosseto. (2017) Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis. Metallomics 9:2, pages 161-174.
Crossref
Crossref
Francisco J Gil-Bea, Garazi Aldanondo, Haizpea Lasa-Fernández, Adolfo López de Munain & Ainara Vallejo-Illarramendi. (2017) Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis. Expert Reviews in Molecular Medicine 19.
Crossref
Crossref
Xin Yi Choo & Alexandra Grubman. 2017. Metals in the Brain. Metals in the Brain
259
268
.
Salil Srivastava, Philip J. Blower, Aisah A. Aubdool, Robert C. Hider, Giovanni E. Mann & Richard C. Siow. (2016) Cardioprotective effects of Cu(II)ATSM in human vascular smooth muscle cells and cardiomyocytes mediated by Nrf2 and DJ-1. Scientific Reports 6:1.
Crossref
Crossref
Erin J. McAllum & David I. Finkelstein. (2016) Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies. Journal of Molecular Neuroscience 60:3, pages 279-288.
Crossref
Crossref
Elisse C. Browne & Belinda M. Abbott. (2016) Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting. European Journal of Medicinal Chemistry 121, pages 918-925.
Crossref
Crossref
Jared R. Williams, Emiliano Trias, Pamela R. Beilby, Nathan I. Lopez, Edwin M. Labut, C. Samuel Bradford, Blaine R. Roberts, Erin J. McAllum, Peter J. Crouch, Timothy W. Rhoads, Cliff Pereira, Marjatta Son, Jeffrey L. Elliott, Maria Clara Franco, Alvaro G. Estévez, Luis Barbeito & Joseph S. Beckman. (2016) Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD. Neurobiology of Disease 89, pages 1-9.
Crossref
Crossref
Eiichi Tokuda & Yoshiaki Furukawa. (2016) Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations. International Journal of Molecular Sciences 17:5, pages 636.
Crossref
Crossref
J. B. Hilton, A. R. White & P. J. Crouch. (2016) Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS. Metallomics 8:9, pages 1002-1011.
Crossref
Crossref
Wouter Hubens & Ayako Okado-Matsumoto. 2016. Redox-Active Therapeutics. Redox-Active Therapeutics
605
626
.
James L. Hickey, Janine L. James, Clare A. Henderson, Katherine A. Price, Alexandra I. Mot, Gojko Buncic, Peter J. Crouch, Jonathan M. White, Anthony R. White, Trevor A. Smith & Paul S. Donnelly. (2015) Intracellular Distribution of Fluorescent Copper and Zinc Bis(thiosemicarbazonato) Complexes Measured with Fluorescence Lifetime Spectroscopy. Inorganic Chemistry 54:19, pages 9556-9567.
Crossref
Crossref
Erin J. McAllum, Blaine R. Roberts, James L. Hickey, Theresa N. Dang, Alexandra Grubman, Paul S. Donnelly, Jeffrey R. Liddell, Anthony R. White & Peter J. Crouch. (2015) ZnII(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism. Neurobiology of Disease 81, pages 20-24.
Crossref
Crossref
Jeffrey R Liddell. (2015) Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration. Neurodegenerative Disease Management 5:4, pages 345-364.
Crossref
Crossref
Masamichi IkawaHidehiko OkazawaTetsuya TsujikawaAkiko MatsunagaOsamu YamamuraTetsuya MoriTadanori HamanoYasushi KiyonoYasunari NakamotoMakoto Yoneda. (2015) Increased oxidative stress is related to disease severity in the ALS motor cortex. Neurology 84:20, pages 2033-2039.
Crossref
Crossref
N. K. H. Lim, L. W. Hung, T. Y. Pang, C. A. Mclean, J. R. Liddell, J. B. Hilton, Q.-X. Li, A. R. White, A. J. Hannan & P. J. Crouch. (2014) Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain. Human Molecular Genetics 23:15, pages 4051-4063.
Crossref
Crossref
A Grubman, A R White & J R Liddell. (2014) Mitochondrial metals as a potential therapeutic target in neurodegeneration. British Journal of Pharmacology 171:8, pages 2159-2173.
Crossref
Crossref
Kevin J. Barnham & Ashley I. Bush. (2014) Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chem. Soc. Rev. 43:19, pages 6727-6749.
Crossref
Crossref
Alexandra Grubman & Anthony R. White. (2014) Copper as a key regulator of cell signalling pathways. Expert Reviews in Molecular Medicine 16.
Crossref
Crossref